Condition: Cluster Headache – Episodic and Chronic
Interventions: Drug: SOM230; Drug: Placebo; Drug: Sumatriptan
Sponsor: Novartis Pharmaceuticals
Recruiting – verified May 2017
Source: ClinicalTrials.gov Listing of Cluster Headache trials
The purpose of this non-confirmatory study is to determine if SOM230 has adequate efficacy and safety to warrant further clinical development in cluster headache (CH). This study will have two parts. Part A will be a parallel design SOM230 vs. Placebo, and following an observed signal in Part A at an interim analysis, Part B of the study will be a comparison of SOM230 to sumatriptan.
2015-11-30